Stock Research: Ramkhamhaeng Hospital

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Ramkhamhaeng Hospital

SET:RAM TH0259010Z02
8
  • Value
    76
  • Growth
    7
  • Safety
    Safety
    6
  • Combined
    4
  • Sentiment
    30
  • 360° View
    360° View
    8
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Ramkhamhaeng Hospital Public Company Limited is a Thailand-based healthcare service provider offering comprehensive medical treatment through physicians and medical professionals. The company's main businesses include operating private hospitals providing a wide range of medical services and selling medical equipment, medicines, and medical supplies, along with offering medical device calibration and laboratory diagnostics services. It operates approximately 14 hospitals across Thailand. In the last fiscal year, the company had a market cap of $631 million, profits of $68 million, revenue of $288 million, and 7699 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
76 77 61 51
Growth
7 1 29 45
Safety
Safety
6 6 14 4
Sentiment
30 37 4 92
360° View
360° View
8 4 4 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
15 19 26 71
Opinions Change
50 50 1 50
Pro Holdings
n/a 16 31 74
Market Pulse
100 96 1 85
Sentiment
30 37 4 92
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
76 77 61 51
Growth
7 1 29 45
Safety Safety
6 6 14 4
Combined
4 4 14 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
80 72 55 52
Price vs. Earnings (P/E)
59 61 36 24
Price vs. Book (P/B)
73 79 64 48
Dividend Yield
79 84 78 69
Value
76 77 61 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
12 11 55 8
Profit Growth
14 16 22 34
Capital Growth
61 23 68 59
Stock Returns
23 7 7 79
Growth
7 1 29 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
28 32 38 32
Refinancing
3 1 1 3
Liquidity
25 29 46 8
Safety Safety
6 6 14 4

Similar Stocks

Discover high‑ranked alternatives to Ramkhamhaeng Hospital and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: